Outcomes of rare patients with a primary cutaneous CD30+ lymphoproliferative disorder developing extracutaneous disease

Blood. 2020 Mar 5;135(10):769-773. doi: 10.1182/blood.2019002799.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Female
  • Follow-Up Studies
  • Humans
  • Incidence
  • Ki-1 Antigen / metabolism
  • Lymphoproliferative Disorders / diagnosis*
  • Lymphoproliferative Disorders / epidemiology
  • Lymphoproliferative Disorders / pathology
  • Lymphoproliferative Disorders / therapy*
  • Male
  • Middle Aged
  • Neoplasm Metastasis
  • Prognosis
  • Recurrence
  • Skin Neoplasms / diagnosis*
  • Skin Neoplasms / epidemiology
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*
  • Treatment Outcome

Substances

  • Ki-1 Antigen